Overview of rectal drug delivery systems.
Importance of systemic absorption and bypassing first-pass metabolism.
Key term: Hepatic portal vein.
Physiology of the Rectal Cavity: Understand the anatomical features.
Physiological Challenges: Identify barriers to effective drug delivery.
Ideal Properties: Physicochemical properties needed for rectal drug delivery systems (DDS).
Formulation Factors: Components affecting formulation success in rectal DDS.
Types of Rectal DDS: Different formulations available.
Patient Conditions: Situations where rectal administration is beneficial.
Local Applications:
Hemorrhoids: Treatment using vasoconstrictors.
Local infections: Use of antibiotics.
Constipation: Administration of laxatives and enemas.
Systemic Applications:
Situations like unresponsive patients (vomiting, seizures).
Drugs unstable in the gastrointestinal tract.
Drugs that irritate the gastrointestinal tract.
Advantages:
Useful for both local and systemic effects.
Bypasses first-pass metabolism.
Beneficial for patients unable or unwilling to take oral medications.
Disadvantages:
Variable bioavailability due to factors like fecal presence.
Patient compliance issues: generally unpopular.
Low absorption rates and administration difficulties.
Retention time challenges and potential local side effects.
Importance of dosage form placement within the rectal cavity for effective drug action.
Volume: Approximately 3mL for effective delivery.
pH Levels: Adults (7.0-8.0), Children (7.2-12.1) with minimal buffering capacity.
Vascularization: Significance of the superior rectal vein and first-pass effect.
Anatomy Considerations: Length of rectum (10-15 cm) and circumference (15-35 cm).
Anal sphincter critical for dosage retention.
Molecular Weight: Low molecular weight (<1,000 Da) ideal for absorption.
Partition Coefficient: Log K_o/w should be between 1 to 3 for optimization.
Dissociation Constant (pKa): Influences unionized species at rectal pH (7).
Particle Size: Affects dissolution rates and absorption.
Vehicle Choice:
Liquids: Faster onset of action.
Solids: Longer drug duration.
pH: Maintain around 7 to reduce irritation and evacuation triggers.
Volume of Administration: Should be a few mL for effective delivery.
Forms Include:
Suppositories.
Rectal enemas.
Rectal gels and foams.
Ointments and creams.
Questions about the Macy Catheter:
Potential uses.
Facilitates quick symptom management in compromised patients.
Aseptic technique requirements during insertion.
Purpose of the balloon and its filling material.
Oleaginous Bases:
Properties: soothing, may stain, melt upon temperature.
Examples: Cocoa butter, Fattibase™, Witepsol®, MBK™.
Water Soluble Bases:
Properties: non-staining, can irritate, dissolve quickly.
Examples: PEGs, glycerinated gelatin.
Composition:
Contains ergotamine tartrate and caffeine.
Dosage: 2mg/100mg.
Indications: Used for migraine treatment.
Excipients: Cocoa butter and tartaric acid.
Special Packaging: Sealed in foil to prevent leakage; chilling required if softening occurs.
Insertion Technique:
Pointed end first, insert until it passes the rectal sphincter.
Depth of insertion: 1/2 - 1 inch for infants, ~1 inch for adults.
Formulation Examples:
Suppositories: Solid bases with drug dissolved or dispersed.
Rectal Enemas: Solutions or suspensions that require longer retention.
Rectal Gels & Foams: Applied with applicators, sometimes messy.
Device Considerations:
Use a finger cot or glove for hygiene.
Application Targets:
Suppositories: Rectal region.
Foams: Sigmoid colon.
Enemas: Descending colon.
Evaluate understanding of rectal dosage forms:
Reasons for variable bioavailability.
Key formulation factors for rectal drug delivery.
Ideal base selection for fast release of hydrophobic drugs in suppositories.
Goals:
Describe the physiology of the rectal cavity.
Explore physiological challenges to drug delivery.
Identify ideal physicochemical properties for rectal DDS.
Recognize formulation factors for rectal DDS.
Review different types of rectal DDS.
Identify patient conditions benefitting from the rectal route.